Phase II trial of amsacrine (m-AMSA) in advanced ovarian carcinoma
- 1 January 1982
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 18 (1) , 71-74
- https://doi.org/10.1016/0277-5379(82)90027-x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- 4′-(9-Acridinylamino) Methanesulfon-m-Anisidide (AMSA): A New Drug Effective in the Treatment of Adult Acute LeukemiaAnnals of Internal Medicine, 1980
- PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF 4'-(9-ACRIDINYLAMINO)-METHANESULFON-META-ANISIDIDE IN CHILDREN WITH CANCER1980
- PHASE-I EVALUATION OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-META-ANISIDIDE (AMSA) BY A WEEKLY IV DOSE SCHEDULE1980
- PHASE-II STUDY OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-M-ANISIDIDE (AMSA) IN METASTATIC BREAST-CANCER1979
- PHASE-1 CLINICAL INVESTIGATION OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-M-ANISIDIDE (NSC 249992), A NEW ACRIDINE DERIVATIVE1978
- INVIVO CHARACTERISTICS OF RESISTANCE AND CROSS-RESISTANCE OF AN ADRIAMYCIN-RESISTANT SUBLINE OF P388 LEUKEMIA1978
- ADRIAMYCIN THERAPY FOR ADVANCED OVARIAN CARCINOMA RECURRENT AFTER CHEMOTHERAPY1978